Cargando…
Studies Recommending Palivizumab Restriction Have Serious Deficiencies
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437328/ https://www.ncbi.nlm.nih.gov/pubmed/20726681 http://dx.doi.org/10.18553/jmcp.2010.16.7.509 |
| _version_ | 1785092496359948288 |
|---|---|
| author | Stewart, Dan L. |
| author_facet | Stewart, Dan L. |
| author_sort | Stewart, Dan L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10437328 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2010 |
| publisher | Academy of Managed Care Pharmacy |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104373282023-08-21 Studies Recommending Palivizumab Restriction Have Serious Deficiencies Stewart, Dan L. J Manag Care Pharm Letters Academy of Managed Care Pharmacy 2010-09 /pmc/articles/PMC10437328/ /pubmed/20726681 http://dx.doi.org/10.18553/jmcp.2010.16.7.509 Text en Copyright © 2010, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
| spellingShingle | Letters Stewart, Dan L. Studies Recommending Palivizumab Restriction Have Serious Deficiencies |
| title | Studies Recommending Palivizumab Restriction Have Serious Deficiencies |
| title_full | Studies Recommending Palivizumab Restriction Have Serious Deficiencies |
| title_fullStr | Studies Recommending Palivizumab Restriction Have Serious Deficiencies |
| title_full_unstemmed | Studies Recommending Palivizumab Restriction Have Serious Deficiencies |
| title_short | Studies Recommending Palivizumab Restriction Have Serious Deficiencies |
| title_sort | studies recommending palivizumab restriction have serious deficiencies |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437328/ https://www.ncbi.nlm.nih.gov/pubmed/20726681 http://dx.doi.org/10.18553/jmcp.2010.16.7.509 |
| work_keys_str_mv | AT stewartdanl studiesrecommendingpalivizumabrestrictionhaveseriousdeficiencies |